SCHEMBL3700281

SCHEMBL3700281

NC(=O)n1c2cc(C(=O)N3CCOCC3)ccc2c2c(-c3cccc4c(C(=O)O)cccc34)cccc21

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.42
MYC P01106 1/20 0.41
CNR1 P21554 1/20 0.41
JAK2 O60674 2/20 0.41
JAK1 P23458 2/20 0.41
TYK2 P29597 2/20 0.41
JAK3 P52333 2/20 0.41
PKM P14618 1/20 0.41
BTK Q06187 3/20 0.40
RORC P51449 1/20 0.40
CNR2 P34972 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PLAUR Q03405 1/20 0.39
CSF1R P07333 1/20 0.39
PDE4B Q07343 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL124373 0.76 BTK (0.66) JAK2JAK1TYK2JAK3BTK
SCHEMBL2464537 0.67 CNR2 (0.42) HPGDCNR1JAK2JAK1TYK2
SCHEMBL3227656 0.67 MEN1 (0.63) HPGDPKMMEN1KMT2A
SCHEMBL30577960 0.65 L3MBTL1 (0.64) HPGDPKMMEN1KMT2A
SCHEMBL1199986 0.65 L3MBTL1 (0.64) HPGDPKMMEN1KMT2A
SCHEMBL367332 0.65 HPGD (0.50) HPGDMYCCNR1JAK2JAK1
SCHEMBL2467176 0.65 PKM (0.41) HPGDCNR1JAK2JAK1TYK2
SCHEMBL10720509 0.65 L3MBTL1 (0.71) HPGDPKMMEN1KMT2A
SCHEMBL28133023 0.65 HRH3 (0.55) HPGDMYCCNR1JAK2JAK1
SCHEMBL365228 0.64 HPGD (0.47) HPGDCNR1JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391602-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-12-07 EP disclosed
WO-2010080481-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 WO disclosed